Jingsong Wang is the founder of Harbour Biomed. Harbour Biomed has raised $177M in total funding. Latest round: Series C. Based in Cambridge, MA, US.
Jingsong Wang is the Founder, Chairman, and CEO of Harbour BioMed, a company focused on developing next-generation biologics for cancer, immunologic diseases, and COVID-19. The company secured a $102.8 million Series C financing round in July 2020, following a $75 million Series B+ in March 2020, bringing its total funding in the first half of 2020 to over $177 million.
Full founder directory · Investor directory · Company funding database · Fundraising library